These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35004910)

  • 21. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
    Pathak R; Katel A; Massarelli E; Villaflor VM; Sun V; Salgia R
    Oncologist; 2021 Dec; 26(12):1052-1061. PubMed ID: 34378270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Checkpoint Inhibition-Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade.
    Nelke C; Pawlitzki M; Kerkhoff R; Schroeter CB; Aktas O; Neuen-Jacob E; Polzin A; Meuth SG; Ruck T
    Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):. PubMed ID: 37884388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?
    Rossi VA; Gawinecka J; Dimitriou F; von Eckardstein A; Dummer R; Ruschitzka F; Matter CM
    ESC Heart Fail; 2023 Aug; 10(4):2680-2685. PubMed ID: 37021424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event.
    Lin X; Guan W; Li B; Deng H; Chen Y; Yang Y; Qiu G; Xie X; Zhou C
    Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):780-787. PubMed ID: 37339370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report.
    Zhou Z; Chen X; Liu G; Pu J; Wu J
    Front Neurol; 2019; 10():770. PubMed ID: 31379720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
    Lipe DN; Galvis-Carvajal E; Rajha E; Wechsler AH; Gaeta S
    Am J Emerg Med; 2021 Aug; 46():51-55. PubMed ID: 33721590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis-a case report.
    Portolés Hernández A; Blanco Clemente M; Escribano García D; Velasco Calvo R; Núñez García B; Oteo Domínguez JF; Salas Antón C; Méndez García M; Segovia Cubero J; Domínguez F
    Cardiovasc Diagn Ther; 2021 Aug; 11(4):1013-1019. PubMed ID: 34527524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathy.
    Arman Ç; Ibrahim K; Elif OK; Hacer D; Yeşim P
    Ideggyogy Sz; 2023 Nov; 76(11-12):422-426. PubMed ID: 38051685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune checkpoint inhibitor-induced myocarditis in lung cancer patients: a case report of sintilimab-induced myocarditis and a review of the literature.
    Bi H; Ren D; Wang Q; Ding X; Wang H
    Ann Palliat Med; 2021 Jan; 10(1):793-802. PubMed ID: 33545801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report.
    Liu S; Ma G; Wang H; Yu G; Chen J; Song W
    Medicine (Baltimore); 2022 Nov; 101(46):e31873. PubMed ID: 36401466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
    Kang KH; Grubb W; Sawlani K; Gibson MK; Hoimes CJ; Rogers LR; Lavertu P; Yao M
    Am J Otolaryngol; 2018; 39(5):642-645. PubMed ID: 29903623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
    Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome.
    Giglio D; Berntsson H; Fred Å; Ny L
    Case Rep Oncol; 2020; 13(3):1252-1257. PubMed ID: 33250739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
    Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
    J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series.
    Longinow J; Zmaili M; Skoza W; Kondoleon N; Marquardt R; Calabrese C; Funchain P; Moudgil R
    Cancer Med; 2023 Feb; 12(3):2281-2289. PubMed ID: 36128926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy.
    Saygin D; Ghosh N; Reid P
    J Clin Rheumatol; 2022 Oct; 28(7):367-373. PubMed ID: 35696731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant cell myositis responsive to combined corticosteroids and immunoglobulin.
    Shah A; Pace A; Hilton D; Househam E; Weatherby S
    Pract Neurol; 2015 Dec; 15(6):456-9. PubMed ID: 26201976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature.
    Cuenca JA; Hanmandlu A; Wegner R; Botdorf J; Tummala S; Iliescu CA; Nates JL; Reddy DR
    BMC Anesthesiol; 2023 Sep; 23(1):310. PubMed ID: 37700240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent/metastatic thymic carcinoma patient: a case report.
    Szuchan C; Elson L; Alley E; Leung K; Camargo AL; Elimimian E; Nahleh Z; Sadler D
    Eur Heart J Case Rep; 2020 Jun; 4(3):1-8. PubMed ID: 32617460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.